GEERS, SARAH,LOWINGER, MICHAEL,MCKELVEY, CRAIG A.,MEYER, ROBERT F.,ZHANG, DINA
申请号：
CA2641451
公开号：
CA2641451C
申请日:
2007.02.09
申请国别(地区):
CA
年份:
2012
代理人:
摘要：
A pharmaceutical composition comprises (a) a CETP inhibiting compound, or apharmaceutically acceptable salt thereof； (b) a concentration-enhancingpolymer； and (c) optionally one or more surfactants； wherein the compound hasthe structure shown as Formula I below. The composition raises HDL-cholesteroland lowers LDL-cholesterol.
